The fundraising was led by MDI Ventures and the Trans-Pacific Technology Fund (TPTF) and participated by existing investors, including Siloam Hospitals Group.
Founded in 2019, the startup currently serves approximately 10 million users comprising a growing network of insurance and corporate members with 24/7 telemedicine and pharmacy delivery services.
The platform allows users to connect directly with primary care services, such as medical teleconsultations, pharmacy delivery, and on-demand laboratory testing. These services saw exponential demand during the pandemic, Prixa said.
The new funding will be used to enable Prixa to scale its platform and user base while supporting Prixa’s B2B customer base and improving the accessibility to healthcare and digital transformation of Indonesia’s health services.
The startup focuses on servicing healthcare payers, which includes insurance companies, corporates, and government entities. It aims to reduce claims and healthcare costs via a managed-care approach.
“This business model is also in sync with Prixa’s support of government programs for digital transformation in the healthcare sector and to improve the delivery of health services across the community,” the company said.
The company believes that data and technology will revolutionize the way healthcare is accessed and delivered; where high quality and affordable healthcare will be the key to enabling a promising future.
Aditia Henri Narenda, GM of legal and corporate communications at MDI Ventures, said the startup “has demonstrated its ability to support insurance companies and hospitals in making medical services more accessible and affordable through its AI telemedicine platform”.
“Prixa has a proven track record in increasing patient’s satisfaction, by delivering fast and usable teleconsultation service, cost of insurance claims can be more efficient with the effective use of telemedicine in primary care, and enabling hospitals to continue to serve patients digitally during the pandemic,” Narenda said.